Companies: 10,795·Total market cap: $144.5T
Arcutis Biotherapeutics, Inc.

Arcutis Biotherapeutics, Inc.

ARQTNASDAQHealthcare● Active
$21.54
+$0.31(+1.46%)
Market Cap$2.7B
P/E Ratio—
52W High$31.77
52W Low$12.72
Overview

Arcutis Biotherapeutics, Inc.（ARQT）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

arqt · 股价预测 · 12 位分析师（近3月）· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 12 位华尔街分析师

SellBuy

Buy

12 位分析师

共识

评级分布

Strong Buy
0
Buy
10
Hold
2
Sell
0
Strong Sell
0
合计: 12 · 买入占比: 83.3%

12 个月目标价

High

$34.00

Consensus

$34.00

+57.8% upside

Low

$34.00

Median: $34 · Last Close: $21.54

Arcutis Biotherapeutics, Inc.（ARQT）的分析师共识为 Buy，基于过去 3 个月内 12 位华尔街分析师的评级。ARQT 的 12 个月平均目标价为 $34.00，相对当前价 $21.54 代表 +57.8% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足，无法为该股票生成预测图表。

短期股价预测

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-09$21.70↑ 0.76%

1-day model range: $21.56–$21.85. Peak: $21.85 (+0.76%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$24+10.5%
2028$25+17.5%
2029$26+22.0%
2030$27+24.8%
2031—+26.5%
Confidence:Medium

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Market Sentiment

NEUTRAL

Based on 14 technical indicators

43%7%50%
6Buy
1Neutral
7Sell
RSI (14)63.3Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · ARQT · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$21.37BUY
MA 10$21.35BUY
MA 20$21.09BUY
MA 50$22.50SELL
MA 100$23.87SELL
MA 200$23.63SELL
Current $ARQT · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$21.43BUY
EMA 10$21.35BUY
EMA 20$21.47BUY
EMA 50$22.32SELL
EMA 100$23.11SELL
EMA 200$22.36SELL
Current $ARQT · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
Needham2026-05-07
Maintains
Buy→Buy
Mizuho2026-03-02
Maintains
Outperform→Outperform
Guggenheim2026-02-27
Maintains
Buy→Buy
TD Cowen2026-02-26
Maintains
Buy→Buy
HC Wainwright & Co.2026-02-26
Maintains
Buy→Buy
Needham2026-02-26
Maintains
Buy→Buy
Needham2026-01-26
Maintains
Buy→Buy
Mizuho2025-11-28
Maintains
Outperform→Outperform
Goldman Sachs2025-10-30
Maintains
Neutral→Neutral
Needham2025-10-28
Maintains
Buy→Buy

Wall Street analysts have recently issued updated ratings on Arcutis Biotherapeutics, Inc. (ARQT) stock. Of the recent 75 rating actions, 3 were upgrades and 3 were downgrades. 12 analysts currently cover ARQT.

分析师推荐趋势

Buy ratings1 → 1
Hold ratings1 → 0↓ 1
Sell ratings0 → 0

ARQT analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

$497M

↓ 36.5% YoY

Revenue Next Year

$646M

↑ 29.9% YoY

EPS This Year

$0.20

EPS Next Year

$1.07

↑ 436.9% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast ARQT EPS of $0.20 for the current fiscal year, based on estimates from 4 analysts. The ARQT revenue forecast is $497M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

ARQT 股价预测由两类独立数据源支撑：来自 12 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。ARQT 的共识目标价为 $34.00（+57.8% 上行空间），分析师共识为 Buy。

ARQT 的短期预测（明日）为 $21.70（+0.76%）。 ARQT 对 2027 年的股价预测均值为 $24。 ARQT 对 2030 年的预测区间为 $25–$29。

Arcutis Biotherapeutics, Inc. 在 NASDAQ 上市，代码 ARQT。ARQT 在 2027 年的整体展望偏积极，在覆盖分析师中约 83% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

相关页面

盈利营收市盈率财务报表市值内幕交易股息价格历史

常见问题

ARQT 预测 · 8 个问题

根据 12 位华尔街分析师，ARQT 的 12 个月平均目标价为 $34.00，最高 $34.00、最低 $34.00。若有图表，中位目标价可在上方查看。相对当前价 $21.54，隐含约 +57.8% 的上行空间。

ARQT 目标价ARQT 分析师目标价ARQT 12个月目标价目标价 ARQT

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.